Innovations in breast metastatic cancer
Frédérique PENAULT LLORCA Pathologist, Clermont Ferrand, France
HR+/HER2- non-metastatic disease adjuvant management in 2022.
Marc SPIELMANN, Joseph GLIGOROV
Radiotherapy options.
Yazid BELKACEMI
Radiotherapist, Créteil, France
Molecular profiling of breast cancers.
Benjamin VERRET
Oncologist, Villejuif, France
Why is the CASCADE study focusing on lung cancer screening in women?
Marie-Pierre REVEL
radiologist, Paris, France - Univeristé Paris Citée, Hôpital Cochin